This is a type of condition where small, round cells called eosinophils gather in certain parts of your body, usually in the bones. It's generally not serious and often doesn't cause any symptoms. Doctors might find it during an X-ray or other tests.
Every report comes from a Lived member, sent anonymously.
Have you had Curettage for Eosinophilic Granuloma?
Eosinophilic granuloma is a rare, usually localized bone disease. A cluster of abnormal immune cells builds up inside a bone and wears away a small area of it, which can cause pain, tenderness or a lump. The skull, jaw, spine, ribs, pelvis and the long bones of the arms and legs are the usual sites. In children the skull is most often affected, while in adults the jaw is also a common site. It is the mildest and most common form of Langerhans cell histiocytosis (LCH), a group of disorders in which cells similar to the immune system's Langerhans cells multiply and collect in tissues. The name comes from what the lesion looks like under a microscope: these cells mixed with eosinophils, a type of white blood cell. About 9 in 10 people have a single lesion in one bone. Some have lesions in several bones, and a smaller number have LCH elsewhere, such as the skin, lungs or pituitary gland, which changes the outlook and the treatment.
Eosinophilic granuloma is not an infection and is not caused by anything a person did. In about half of people with LCH, the abnormal cells carry an acquired change in a gene called BRAF, and most other cases have changes in related genes on the same cell-growth pathway. These changes arise in the cells themselves and are not usually inherited. For this reason LCH is now classed as a disorder of blood-forming cells, even though a single bone lesion often behaves more like a self-limiting inflammation than a cancer. It most often appears in children and young adults, but it can occur at any age. Apart from these genetic findings, no clear cause has been established for bone disease. In adults, LCH that affects the lungs is strongly linked to smoking, which is one reason a care team asks about it.
The first clue is usually an X-ray taken for bone pain or a lump, showing a sharply edged hole in the bone, often described as punched out. When it affects a vertebra, the bone may partly collapse into a thin, flat shape (vertebra plana). An MRI (magnetic resonance imaging) or CT (computed tomography) scan shows how far the lesion extends, including into nearby soft tissue or toward the spinal cord. The same X-ray picture can come from infection, other benign bone lesions or bone cancers such as Ewing sarcoma, so a biopsy is normally needed to confirm the diagnosis. A pathologist looks for the characteristic cells and uses special stains, called CD1a and langerin (CD207), that identify them. The sample may also be tested for a BRAF change. For an isolated collapsed vertebra, where a biopsy carries more risk, specialists sometimes rely on imaging and close follow-up instead. Once the diagnosis is made, the next step is to look for lesions elsewhere, because treatment depends on how widespread the disease is. Children usually have a skeletal survey (X-rays of the whole skeleton), while adults are usually advised to have a whole-body PET-CT (positron emission tomography) scan, which pairs CT images with a tracer that highlights active disease. Blood tests, and sometimes a check of urine concentration for a pituitary hormone problem, complete the picture.
A single bone lesion often needs little treatment. The biopsy itself is frequently combined with curettage, scraping out the abnormal tissue, and many lesions then heal on their own. Some regress even without that. When symptoms fade quickly after biopsy, careful observation with repeat imaging is a reasonable choice. Large removals are avoided because they leave a bigger bone defect without improving results. More treatment is considered when a lesion is in a weight-bearing bone, threatens the spinal cord, is causing deformity, severe pain or loss of function, or does not heal. Local options include a steroid injected directly into the lesion, and for some adults a low dose of radiation, which is effective for a small number of painful bone lesions. Most pediatric specialists now avoid radiation in children because of long-term effects. Bisphosphonates, bone-strengthening medicines such as zoledronic acid, have relieved pain and helped lesions heal in many people with bone-only disease. Systemic treatment, medicine that works throughout the body, is used when there are lesions in several bones, when a lesion sits in certain skull bones around the eye, ear or skull base, or when the disease cannot be reached locally. In children this usually means the chemotherapy drug vinblastine with prednisone, a steroid, for up to a year. In adults, the chemotherapy drugs cytarabine or cladribine are generally preferred. Targeted pills that block the overactive growth signal (BRAF or MEK inhibitors) can work quickly for selected people with more extensive disease, but they usually need to be continued, because the disease tends to return when they stop.
Most single bone lesions heal, sometimes after the biopsy alone, and the long-term outlook in both children and adults is very good. Healing is tracked with repeat imaging, and a weakened bone may need some protection while it repairs, which the orthopedic team will advise on. The disease can return, either at the same spot or as a new lesion elsewhere. In one adult series, about 1 in 5 people with a single lesion later developed disease at another site, which was then treated successfully. Reactivation is more common when several bones were involved from the start. For this reason follow-up continues for years, with symptom checks and repeat imaging that becomes less frequent once the disease is quiet. Some adults have lasting pain at the site of a healed lesion, or fatigue, even when scans show no active disease. These symptoms are recognized by specialists and are worth raising, since pain management and support can help. Because LCH is rare, care is often coordinated by a hematology or oncology team with experience in histiocytic disorders, alongside orthopedic and endocrine specialists as needed.
Arrange a medical visit for bone pain that persists in you or your child, a firm lump on the skull or another bone, or swelling over a bone without a clear injury. After treatment, report new bone pain, a new lump, a rash that does not clear, or ear discharge, since these can signal that the disease has returned. Contact the care team promptly about a new, strong thirst with frequent urination, including waking at night to urinate. This can mean the pituitary gland is affected (diabetes insipidus), which needs assessment and often hormone treatment. If someone with a known or suspected spine lesion develops new weakness or numbness in the legs, or new trouble controlling the bladder or bowels, go to an emergency department right away (or call 911 if they cannot get there safely), because this can mean pressure on the spinal cord.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Eosinophilic Granuloma is like, what's helped you, or ask the community a question.